John Heymach, MD, PhD

Articles by John Heymach, MD, PhD

John Heymach, MD, PhD, Discusses the Use of Adjuvant Immunotherapy for Patients With NSCLC

July 23rd 2021

CancerNetwork® sat down with John Heymach, MD, PhD, at the 2021 American Society of Clinical Oncology Annual Meeting to talk adjuvant immunotherapy for recurrence-free survival in resected non–small cell lung cancer.

Latest Updated Articles

Trending on CancerNetwork

FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma

How ADCs are Replacing Chemotherapy as Breast Cancer Treatment

Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma

How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?

Trial Assessing Savolitinib/Osimertinib in NSCLC Completes Enrollment